Drug intelligence / Profile preview

furanyl fentanyl

Development stage
Discontinued
Modality
Small Molecules
Administration
Oral, Nasal/intranasal, Inhalation/smoked, Injection, Sublingual, Transdermal
01

Overview

Furanyl fentanyl is a **synthetic opioid analgesic** and a structural analog of fentanyl. It consists of the fentanyl core structure, with a furan-2-carboxamide group replacing the propionamide moiety of fentanyl. Like other fentanyl analogs, furanyl fentanyl acts as a **potent agonist at the mu-opioid receptor**, responsible for its powerful analgesic and sedative effects. Furanyl fentanyl is not used clinically and is considered a **designer drug** that has emerged on illicit drug markets. It is classified as a Schedule I controlled substance in the United States and other jurisdictions, indicating no accepted medical use and a high potential for abuse. Relative to fentanyl, furanyl fentanyl possesses similar or slightly lower potency, but significant toxicity and a high risk of overdose, including fatal respiratory depression. Its metabolism primarily involves amide hydrolysis and oxidative transformation of the furanyl ring[2][5].

Other names
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamideN-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide2-furanoylfentanylfuranylfentanyl
02

Targets

MOR (Mu opioid receptor)

Beyond the preview

Go deeper on furanyl fentanyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on furanyl fentanyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call